Will AstraZeneca Have a Big Market for Its COVID-19 Therapy?
16/10 14:01
AstraZeneca (NASDAQ: AZN) still isn't a player in the U.S. market with its COVID-19 vaccine. However, the big drugmaker recently filed for U.S. Emergency Use Authorization (EUA) for a promising COVID-19 antibody therapy. In this Motley Fool Live video recorded on Oct. 6, Motley F...